News for '-ebitda'

Demand woes likely to keep a lid on HUL stock in near term

Demand woes likely to keep a lid on HUL stock in near term

Rediff.com24 Jan 2025

The October-December quarter (Q3FY25) results of fast moving consumer goods (FMCG) major Hindustan Unilever (HUL) indicated weak demand, with urban growth muted and rural showing recovery. Consolidated revenue grew by 1.6 per cent (volume was flat) to Rs 15,818 crore, due to price hikes. Prices of key raw materials such as palm oil and tea remained elevated, leading to compression of gross margin.

Auto revenue may hit high gear on rural push, launches

Auto revenue may hit high gear on rural push, launches

Rediff.com28 Jan 2025

Overall, volume growth is likely to be in the range of 3-8 per cent for two-wheelers and 5-7 per cent for passenger vehicles owing to healthy demand from urban and rural areas and pending order books.

RIL to pump Rs 1.5 trn into petro, new energy

RIL to pump Rs 1.5 trn into petro, new energy

Rediff.com28 Apr 2025

Mukesh Ambani-led Reliance Industries Ltd (RIL) plans to invest Rs 75,000 crore ($9 billion) each into its new energy business and petrochemical expansion, according to a company presentation. In its FY25 result statement, Ambani said the company has laid a strong foundation for its projects in renewable energy and battery operations. "In the coming quarters, we will see the transition of this business from incubation to operationalisation.

Q3 results preview: FMCG stocks vs capital goods sector

Q3 results preview: FMCG stocks vs capital goods sector

Rediff.com13 Jan 2025

Fast-moving consumer goods (FMCG) companies are expected to witness pressure on volumes in the October-December quarter. However, price hikes will help push up revenues, said brokerages.For India's largest engineering firm, Larsen and Toubro (L&T), the analysts expect a 20 per cent growth in consolidated revenue, and an 8.1 per cent core business Ebitda margin, up 40 bps from a year ago.

Core acquisition adds to Metropolis Healthcare's long-term growth plans

Core acquisition adds to Metropolis Healthcare's long-term growth plans

Rediff.com27 Dec 2024

Metropolis Healthcare (MHL) has decided to acquire a 100 per cent stake in Gurgaon-based Core Diagnostics for Rs 247 crore. This is about 2.2x FY24 (financial year 2023-24) enterprise value (EV)/sales and estimated 14x FY26 EV/Ebitda for the deal.

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Rediff.com13 Nov 2024

Gland Pharma beat muted expectations for Q2FY25. There was increased Ebitda (Earnings before interest, taxes, depreciation and amortisation) loss at Cenexi, the CRAM subsidiary. However, overall Ebitda margin was better than expectations at 21.1 per cent. But given two years of earnings decline in FY23 and FY24, the business may have bottomed and upper-teens EPS (earnings per share) growth looks possible over next two financial years.

How ITC plans to build a future-ready portfolio

How ITC plans to build a future-ready portfolio

Rediff.com6 May 2025

There remains a debate on who said this: "When the facts change, I change my mind. What do you do, Sir?" Was it the British economist John Maynard Keynes or the American economist Paul Samuelson. Irrespective of who said it, this sentiment appears to have found resonance in ITC's boardroom in recent years.

Apollo Hospitals to expand presence in metros with five new hospitals

Apollo Hospitals to expand presence in metros with five new hospitals

Rediff.com12 Feb 2025

Apollo Hospitals Enterprise is set to expand presence in metro cities during FY26 with the addition of five hospitals that would add over 1,400 beds.

Private Hospitals to Add 34,000 Beds by FY29

Private Hospitals to Add 34,000 Beds by FY29

Rediff.com17 Apr 2025

Leading chains plan Rs 40K crore infra revival to close capacity gap over next 3-5 years

Is it time to buy or sell Delhivery shares?

Is it time to buy or sell Delhivery shares?

Rediff.com11 Feb 2025

Delhivery share price dropped 6.6 per cent to a low of ?295.8 per share on the BSE on Monday after analysts cut their earnings estimate on the stock, following weak results for the December quarter (Q3) of the current financial year (FY25). Q3 is a seasonally strong quarter due to festive pick-up in demand.

Ola Electric is accelerating profitability drive

Ola Electric is accelerating profitability drive

Rediff.com27 Feb 2025

Ola Electric has eliminated its regional warehouses across India, and will now leverage its 4,000 retail stores nationwide for maintaining vehicle inventory, spare parts, accessories, and last-mile deliveries. The strategic move is expected to boost EBITDA margins by almost 10 percentage points, besides improving inventory management and faster customer deliveries, sources directly familiar with the matter said.

RIL focuses on cost control in O2C segment in Q3FY25

RIL focuses on cost control in O2C segment in Q3FY25

Rediff.com27 Jan 2025

Oil-to-telecom conglomerate Reliance Industries Ltd (RIL) has surprised the street with a better than expected performance in its oil-to-chemicals (O2C) division in October-December 2024 (Q3FY25). RIL executives attributed it to favourable feedstock sourcing and higher volumes. However, they also listed cost optimisation and other measures.

Dabur stock fall may provide entry to long-term investors

Dabur stock fall may provide entry to long-term investors

Rediff.com12 Nov 2024

Dabur's performance in the July-September quarter of the current financial year (Q2FY25) was weak but in line with consensus. Consolidated revenue declined 5 per cent year-on-year (Y-o-Y) due to a temporary adjustment in General Trade (GT) inventory. Indian revenue declined 7.6 per cent, while international business grew 13 per cent Y-o-Y in constant currency (CC) terms.

Reliance Q3 net rises 7.4% on rebound in retail, higher telecom earnings

Reliance Q3 net rises 7.4% on rebound in retail, higher telecom earnings

Rediff.com16 Jan 2025

Reliance Industries Ltd on Thursday reported a 7.4 per cent rise in its December quarter net profit, as its retail business rebounded and telecom earnings rose. Its consolidated net profit of Rs 18,540 crore, or Rs 13.70 per share, in October-December - the third quarter of April 2024 to March 2025 fiscal (FY25) - compared to Rs 17,265 crore, or Rs 12.76 a share, in the same period a year back, according to a stock exchange filing by the company.

Despite short-term blip, Sun Pharma remains favourite among investors

Despite short-term blip, Sun Pharma remains favourite among investors

Rediff.com28 Dec 2024

Around six weeks ago, Sun Pharmaceutical Industries, India's largest drugmaker, suffered a setback, which led to a selloff in the share. The US District Court of New Jersey granted Incyte's request for a preliminary injunction against Sun Pharma's launch of Leqselvi, a drug that treats alopecia.

'Swiggy Is Now Focusing On Overall Growth'

'Swiggy Is Now Focusing On Overall Growth'

Rediff.com16 Dec 2024

'Expect our food delivery business to deliver sustainable adjusted EBITDA margins of about 5 per cent in the medium term.'

ITC demerger: Analysts upbeat on ITC share outlook; support seen at Rs 442

ITC demerger: Analysts upbeat on ITC share outlook; support seen at Rs 442

Rediff.com2 Jan 2025

With just four trading sessions to go for the ITC-ITC Hotels demerger record date shares of ITC continue to consolidate in a thin range of Rs 460 - Rs 480 in an otherwise volatile equity market. On Tuesday thus far despite a near 1 per cent fall in the Sensex and Nifty; ITC traded on a flat note. ITC had set the demerger ratio at 1:10 - meaning 1 share of ITC Hotels for every 10 shares of ITC as of the record date January 6, 2025.

PVR Inox shares hit 44-month low; stock has tanked 23% from December high

PVR Inox shares hit 44-month low; stock has tanked 23% from December high

Rediff.com8 Jan 2025

PVR Inox shares hit a 44-month low of Rs 1,154, declining 8 per cent on the BSE in Tuesday's intra-day trade in an otherwise firm market, driven by growth concerns. The stock has slipped 23 per cent from its December high of Rs 1,620, touched on December 5, 2024. It has fallen below its previous low of Rs 1,203.7 from June 4, 2024, and is trading at its lowest level since May 2021.

O2C drag clogs RIL's flow

O2C drag clogs RIL's flow

Rediff.com23 Oct 2024

Reliance Industries' (RIL's) oil-to-chemicals (O2C) business is likely to remain under pressure for the remaining of the current financial year, according to analysts and company executives. "Management guides for softness for the next couple of quarters in both retail and O2C businesses," analysts at BOB Capital Markets noted in an after-results report on RIL. For the July-September quarter (Q2) of 2024-25 (FY25), RIL's O2C business reported a 5.1 per cent year-on-year increase in revenue to Rs 1.55 trillion.

Adani Wilmar Q3 profit more than doubles to Rs 411 cr

Adani Wilmar Q3 profit more than doubles to Rs 411 cr

Rediff.com27 Jan 2025

Adani Wilmar on Monday posted over twofold jump in consolidated net profit at Rs 410.93 crore for December quarter 2024-25 on strong edible oil sales. The company had logged a net profit of Rs 200.89 crore in the year-ago period.

Why time is right to invest in Zomato, Swiggy shares

Why time is right to invest in Zomato, Swiggy shares

Rediff.com20 Mar 2025

After a massive selloff in the shares of food delivery giants Zomato and Swiggy, analysts believe the time may be right for investors to start adding these stocks to their portfolio carts. Their optimism, they say, stems from the sharp correction in stock prices and valuations, which seem to have "over-baked" concerns about the two companies.

TaMo in driver's seat to combat headwinds

TaMo in driver's seat to combat headwinds

Rediff.com20 Mar 2025

Automobile giant Tata Motors' shares were in demand on Wednesday as the stock rallied as much as 3.69 per cent to hit an intraday high of Rs 671.80 per share, before settling 3.18 per cent higher at Rs 668.45. By comparison, the BSE Sensex settled 0.10 per cent, or 72.56 points, lower at 74,029.76.

Lower input costs may aid pharma firms' Q2 margins

Lower input costs may aid pharma firms' Q2 margins

Rediff.com21 Oct 2024

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and amortisation) margins are anticipated to improve by about 110 basis points. Ebitda improvement will be led by lower input costs because prices of active pharmaceutical ingredients (APIs) are 5-15 per cent lower year-on-year (Y-o-Y). Axis Capital said sales growth would be around 10 per cent, of which growth in the India market would be 11 per cent or so.

Adani crisis: No negative actions so far by lenders, investors, says Crisil

Adani crisis: No negative actions so far by lenders, investors, says Crisil

Rediff.com29 Nov 2024

Backing embattled Adani Group, rating agency CRISIL Ratings on Friday said the conglomerate has sufficient liquidity and operational cash flows to meet debt obligations and committed capex and that there has been no negative actions so far by lenders and investors following the US indictment of group founder chairman. The Adani Group, which has the flexibility to reduce certain discretionary capital expenditure (capex) depending on developments in financial markets and future capital availability, has a healthy Ebitda and cash balance that reduces its dependence on external debt to sustain operations, it said in a bulletin.

Sebi tightens norms for SME IPOs

Sebi tightens norms for SME IPOs

Rediff.com10 Mar 2025

Markets regulator Sebi has notified a stricter regulatory framework for small and medium enterprise (SME) IPOs by introducing a profitability requirement and capping a 20 per cent limit on offer-for-sale (OFS). The reforms aim to provide SMEs with a sound track record an opportunity to raise funds from the public while protecting investor interests. This move follows a rise in SME issues, which has driven significant investor participation.

Dealers optimistic about future of cement industry

Dealers optimistic about future of cement industry

Rediff.com16 Mar 2025

After several years of consolidation and price weakness, the cement industry may be moving towards a more stable phase. Pan-Indian, average cement prices have risen through the past three months consecutively.

This is one of the largest health-care deals in India

This is one of the largest health-care deals in India

Rediff.com13 Dec 2024

'Along with Blackstone, we would be keen to look at opportunities in the North.'

Reliance back on growth path, multiple catalysts to drive performance

Reliance back on growth path, multiple catalysts to drive performance

Rediff.com19 Jan 2025

Reliance Industries Ltd, India's most valuable company, is back on a growth path after six months of challenges as it posted better than expected earnings in the December quarter, brokerages said.

Why brokerages have revised their target prices for DMart

Why brokerages have revised their target prices for DMart

Rediff.com14 Jan 2025

Brokerages on DMart Q3 results: Avenue Supermarts (DMart) shares slipped as much as 5.74 per cent to hit an intraday low of Rs 3,474 per share on Monday. However, the stock recovered slightly to close at Rs 3,507.95, down 4.82 per cent. Notably, the 52-week low for DMart shares is Rs 3,400. The downward movement in DMart's share price was triggered by the company's 2024-25 (FY25) October-December quarter (Q3) results, which missed Street expectations.

Blinkit vs Instamart: Chasing a moving target in quick commerce race

Blinkit vs Instamart: Chasing a moving target in quick commerce race

Rediff.com6 Dec 2024

Competition in the fast-growing quick commerce sector is heating up as Swiggy Instamart faces a tough challenge in narrowing the gap with Blinkit, which currently dominates the market. In the second quarter (Q2) of 2024-25 (FY25), Instamart's gross order value (GOV) rose by 42.1 per cent quarter-on-quarter (Q-o-Q) and 75.5 per cent year-on-year (Y-o-Y), reaching Rs 3,382 crore.

Mutual Funds Emerge As Financiers For M&A Deals

Mutual Funds Emerge As Financiers For M&A Deals

Rediff.com6 Feb 2025

'Growth for some companies has been hard to come by and this is a smart way to get there.'

Factors that will support credit access of India Inc in FY26

Factors that will support credit access of India Inc in FY26

Rediff.com13 Jan 2025

Fitch Ratings on Monday said India's steady GDP growth outlook, improved banking sector's financial health and expected interest-rate cuts in 2025 will support credit access for corporates in FY26.

Apollo Hospitals to ride on healthy growth outlook

Apollo Hospitals to ride on healthy growth outlook

Rediff.com24 Aug 2024

Apollo Hospitals Enterprise (APH) delivered an in-line performance for the April-June quarter of the financial year 2024-2025 (Q1FY25)with growth in the number of patients. AHLL (Apollo Health & Lifestyle), a subsidiary, posted sales growth and profitability. APH also reduced operational costs at Healthco.

O2C biz may drag RIL to another weak quarter

O2C biz may drag RIL to another weak quarter

Rediff.com9 Oct 2024

For Reliance Industries Ltd (RIL), the September 2024 quarter (Q2FY25) may turn out to be yet another weak one as refining margins drag, say analysts. Two brokerage firms - ICICI Securities and Nuvama - expect a 1-13 per cent dip in reported profits in Q2FY25 from a year ago. Kotak Institutional expects a modest 2.2 per cent rise. Revenue, at best based on available analyst estimates, could rise up to 4 per cent.

Siemens stock drops rapidly as management flags growth challenges ahead

Siemens stock drops rapidly as management flags growth challenges ahead

Rediff.com31 Dec 2024

Siemens's share price has lost ground in the past few sessions following weak management commentary. The management indicated challenges to the growth outlook due to stagnant private capex and concerns over semiconductor shortages for digital industries. Government infra-spending may regain momentum from January 2025.

Udaan set for IPO as NCLT clears demerger plan

Udaan set for IPO as NCLT clears demerger plan

Rediff.com15 Jan 2025

Udaan, India's largest business-to-business (B2B) e-commerce company, has received approval from the National Company Law Tribunal (NCLT) for its internal corporate restructuring plan, according to sources. By consolidating into a single entity, the restructuring will enhance Udaan's agility and pave the way for various financing options, including the ability to pursue an initial public offering (IPO) in India by 2026, according to people familiar with the matter.

RIL's Q2 net falls 5% on weak O2C business

RIL's Q2 net falls 5% on weak O2C business

Rediff.com14 Oct 2024

Reliance Industries Ltd on Monday reported a 5 per cent fall in the net profit for the July-September quarter, as weak oil refining and petrochemical business hurt operational performance.

Varun Beverages' growth strategy could help investors reap benefits

Varun Beverages' growth strategy could help investors reap benefits

Rediff.com20 Dec 2024

The VBL board approved the purchase of SBC Tanzania for Rs 1,304 crore and SBC Beverages Ghana for Rs 127 crore. These own manufacturing/distribution rights for NARTD (PepsiCo branded) beverages in Tanzania and Ghana. The acquisitions will help VBL gain ground in East and West Africa.

Airtel may see highest revenue growth, user addition in Q3

Airtel may see highest revenue growth, user addition in Q3

Rediff.com16 Jan 2025

Bharti Airtel is expected to see its highest revenue growth, and subscriber addition during the third quarter (October-December) of FY25 among telcos, said analysts. The telco's top line in Q3 may see the fastest sequential growth at 5 per cent compared to 3 per cent for Reliance Jio and Vodafone Idea (Vi). Airtel's annual mobile revenue growth would rise to 16 per cent, IIFL Capital said in an analyst note.

India Inc earns fat profits but wages have not kept pace

India Inc earns fat profits but wages have not kept pace

Rediff.com1 Feb 2025

Growth in corporate profits needs to be commensurate with wages to boost the economy, Economic Survey 2024-25 said, noting that sharp disparities between the two pose risk to the economy by curbing demand. The document tabled in Parliament on Friday noted that while the labour share of GVA (gross value added) shows a slight uptick, the disproportionate rise in corporate profitsredominantly among large firmsaises concerns about income inequality.